Sign in
CRVO Stock Price, Chart, Stats & News
CervoMed Inc.
Save
CervoMed Inc. (CRVO) does not currently pay a dividend.
28.52M
Market cap
–
Current P/E
–
Forward P/E
CRVO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -8771.73% |
Pretax margin | -8359.88% |
Net margin | -8359.88% |
Effective tax rate | – |
ROA | -115.24% |
ROE | -96.04% |
D/E | – |
Interest coverage ratio | – |
CRVO valuation
P/E | – |
P/S | 106.78x |
P/B | 1.89x |
P/CF | -1.47x |
P/FCF | -1.47x |
P/OCF | -1.47x |
PEG | 0.37x |
EV multiple | -1.53x |
About
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression.
Similar securities
Based on sector and market capitalization
Report issue